Background: It has been suggested that the −344C/T polymorphism in the CYP11B2 gene is involved in the development of hypertension. However, the results have been inconsistent. In this study, a meta-analysis was performed to clarify the association of −344C/T polymorphism in the CYP11B2 gene with hypertension risk in the Chinese population. Methods: Published literature from PubMed, Chinese National Knowledge Infrastructure (CNKI) and Wan Fang data were retrieved. Pooled odds ratios (ORs) with 95% confidence intervals (CIs) were calculated using a fixed or random effects model. Results: A total of 29 studies (8482 cases/8560 controls) were included in the final meta-analysis. Overall, there was a significant association between −344T/C polymorphism in the CYP11B2 gene and hypertension in the Chinese (heterogeneous co-dominant model: OR=1.10, 95% CI=1.03-1.17, I 2 =12.7%, p for heterogeneity=0.271; dominant model: OR=1.11, 95% CI=1.02-1.20, I 2 =32.1%, p for heterogeneity=0.051; allelic model: OR=1.08, 95% CI 1.01-1.16, p for heterogene-ity=0.006). In the stratified analysis, the effect size was significant only in the Han Chinese (heterogeneous co-dominant model: OR=1.11, 95% CI=1.03-1.20, I 2 =0.0%, p for heterogeneity=0.745; dominant model: OR=1.11, 95% CI=1.02-1.21, I 2 =18.1%, p for heterogeneity=0.299; allelic model: OR=1.09, 95% CI 1.00-1.18, p=0.028), but not in the minority Chinese. Conclusions: Our study suggested that the −344T/C polymorphism in the CYP11B2 gene was significantly associated with hypertension in the Chinese population, especially in the Han Chinese.
Introduction
Hypertension, affecting nearly 1/3 of the adult population worldwide, is a major risk factor for cardiovascular disease. 1 Lifestyle factors, including high salt intake, obesity, and lack of physical activity, contribute to the development of hypertension. 2 However, genetic factors also play key roles in the pathogenesis of this disease. Actually, approximately 30-60% variation of blood pressure is determined by genetic factors. 3 Recently, four genome-wide association studies with very large sample size have identified many hypertension susceptibility loci. [4] [5] [6] [7] However, previous candidate gene studies have provided limited consistent evidence of hypertension genetic loci, suggesting that very large sample size is needed to identify the variants with small effects.
The renin-angiotensin-aldosterone system is an important regulator of blood pressure. 8 Aldosterone hormone is synthesized by the aldosterone synthase enzyme, which is encoded by the CYP11B2 gene located on chromosome 8q22. The −344C/T (rs1799998) polymorphism in the CYP11B2 gene, located at a putative binding site for the steroidogenic transcription factor (SF-1), 9 has been associated with hypertension. However, the results have been inconsistent. One previous meta-analysis 10 indicated that −344C/T polymorphism was significantly associated with hypertension in Europeans (CC vs. TT: odds ratio (OR) =0.70, 95% confidence interval (CI) 0.59-0.83) but not in the Japanese (CC vs. TT: OR=0.85, 95% CI 0.69-1.03). A very recent study 11 with larger sample size (3460 cases and 5811 controls) suggested that there was a significant association between −344C/T polymorphism and hypertension in the Japanese population (T vs. C: OR=1.15, 95% CI 1.08-1.23). In addition, two meta-analyses 12, 13 of the Chinese studies revealed discrepant results, with one 12 indicating significant association and the other 13 suggesting no association. Moreover, 11 additional new studies have been recently published since those two meta-analyses.
In this study, therefore, we performed an updated meta-analysis to further clarify the association between −344C/T polymorphism and hypertension in a Chinese population.
Materials and methods

Literature and search strategy
We searched the literature databases including PubMed, Chinese National Knowledge Infrastructure (CNKI) and Wan Fang data. The search strategy to identify all possible studies involved the use of the following key words: (the aldosterone synthase gene or CYP11B2) and (variant or variation or polymorphism) and hypertension and Chinese. All related studies published in English and Chinese languages were included. The reference lists of retrieved articles were manually searched. If more than one article was published using the same data, only the study with the largest sample size was included. The literature search was updated on 10 August 2012.
Inclusion criteria and data extraction
The studies included in the meta-analysis had to meet all the following inclusion criteria: (1) evaluated the association of −344T/C polymorphism in the CYP11B2 gene with hypertension; (2) used case-control or cohort design; (3) provided sufficient data for calculation of OR with 95% CI; (4) were carried out in the Chinese. The following information was extracted from each study: (1) name of the first author; (2) year of publication; (3) region; (4) nationality; (5) sample size of cases and controls; (6) genotype distribution in cases and controls; (7) definitions for cases and controls; and (8) p value for Hardy-Weinberg equilibrium (HWE) test in controls. The two authors independently assessed the articles for compliance with the inclusion/exclusion criteria, resolved disagreements and reached a consistent decision.
Statistical analysis
The association of −344T/C polymorphism in the CYP11B2 gene with hypertension was estimated by calculating pooled OR and 95% CI under co-dominant, dominant, recessive genetic, and allelic models. The significance of pooled OR was determined by Z test (p<0.05 was considered statistically significant). Q test was performed to evaluate the between-study heterogeneity. A random (DerSimonian-Laird method 14 ) or fixed (Mantel-Haenszel method 15 ) effects model was used to calculate pooled OR in the presence (p≤0.10) or absence (p>0.10) of heterogeneity, respectively. Subgroup analyses by nationality and sample size in cases were performed. Sensitivity analysis was performed by excluding one study at a time. Begg's funnel plot, a scatter plot of effect against a measure of study size, was generated as a visual aid to detect bias or systematic heterogeneity. 16 Publication bias was assessed by Begg's test and Egger's test 17 (p<0.05 was considered statistically significant). Data analysis was performed using STATA version 11 (StataCorp LP, College Station, TX, USA).
Results
Characteristics of the studies
The literature search identified a total of 159 potentially relevant papers. Of these, 104 papers were excluded because of obvious irrelevance on reading the titles and abstracts (e.g. other diseases, functional studies and experimental studies). In addition, four reviews, two meta-analyses, two family-based articles, and one article which investigated the association of other polymorphisms in the CYP11B2 gene with hypertension were excluded. Forty-six papers met the primary inclusion criteria. However, 13 duplicated publications and eight studies in which the variant was not in HWE in controls were further excluded. In addition, since more than one study was included in the articles by Tang et al. 18 , Xu et al. 19 and Mi et al. 20 , they were considered as separate studies in the meta-analysis. Finally, 29 studies (8482 cases/8560 controls) from 25 articles were included in the meta-analysis. A flow chart summarizing the process of study inclusion is depicted in Figure 1 . The characteristics of the included studies are listed in Supplementary Table 1 .
Meta-analysis results
Overall, there was a significant association between −344T/C polymorphism in the CYP11B2 gene and hypertension in the Chinese (TC vs. TT: OR=1.10, 95% CI=1.03-1.17, I 2 =12.7%, p for heterogeneity=0.271; dominant model: OR=1.11, 95% CI=1.02-1.20, I 2 =32.1%, p for heterogeneity=0.051; allelic model: OR=1.08, 95% CI 1.01-1.16, p for heterogeneity=0.006; Figure 2 and Table 1 ). In the stratified analysis, the effect size was significant only in the Han Chinese (TC vs. TT: OR=1.11, 95% CI=1.03-1.20, I 2 =0.0%, p for heterogeneity=0.745; dominant model: OR=1.11, 95% CI=1.02-1.21, I 2 =18.1%, p for heterogeneity=0.299; allelic model: OR=1.09, 95% CI 1.00-1.18, p=0.028; Supplementary Figure 1 and Table  1 ), but not in the minority Chinese. In the further subgroup analysis by sample size in cases, we found a significant association only in the studies with more than 500 cases (dominant model: OR=1.11, 95% CI 1.01-1.22, I 2 =5.1%, p for heterogeneity=0.377, Supplementary  Figure 2 and Table 1 ), but not in those with fewer than 500 cases.
Sensitivity analysis
Sensitivity analysis was performed by excluding one study at a time. Results for the association between −344T/C polymorphism and hypertension remained statistically significant, with OR and 95% CI ranging from 1 
Discussion
The present meta-analysis indicated that −344T/C polymorphism in the CYP11B2 gene was significantly associated with hypertension in the Chinese population, especially in the Han Chinese. The result was based on 29 studies with 17 042 individuals, twice as large as the samples in the two previous meta-analyses of Chinese studies; therefore, we believe that our conclusion was more credible. In addition, our result was consistent with findings in European 10 and Japanese 11 populations, suggesting that the effect of −344T/C polymorphism on hypertension is similar across different ethnic populations, although the minor allele frequency varied among Europeans, Chinese and Japanese (0.433 in HapMap-CEU, 0.259 in HapMap-CHB, 0.349 in HapMap-JPT).
China has 56 different national groups, with Han Chinese accounting for the majority (approximately 93%) of all Chinese. Nationality may act as a key variable affecting the association of gene loci with hypertension. Therefore, we performed a subgroup analysis by nationality. The results demonstrated that the effect size was significant only in the Han Chinese, but not in the minority Chinese. In addition, studies with a small sample size may overestimate the true association, compared with those with a large sample size; 43 a large study with either finding might reflect a true association, as it has sufficient statistical power. Therefore, we performed another sub-analysis stratified by number of cases. The results suggested that the effect size was significant only in studies with more than 500 cases but not in those with fewer than 500 cases, suggesting the credibility of the significant association between −344T/C polymorphism and hypertension in the Chinese population.
The biological mechanism through which −344T/C polymorphism may affect hypertension is unclear. The −344T/C variant by itself does not directly influence promoter activity, despite its location within a SF-1 binding site. Rather, binding of SF-1 to this site downregulates activity of CYP11B2 promoter by making SF-1 less available to functionally affect other CYP11B2 promoter sites. 44 In addition, it is indicated that this polymorphism either increases aldosterone to renin ratio in essential hypertensives or decreases aldosterone production, leading to sodium wasting and decreased excretion of potassium. 45 The current meta-analysis has some advantages compared with other individual studies; however, it does have some limitations. First, the meta-analysis was based primarily on unadjusted ORs with 95% CIs because of the unavailability of adjusted estimates from the primary publications, and confounding factors might influence the precision of effect estimates. Second, the effects of genegene and gene-environment interactions were not addressed in this meta-analysis, since no related data were provided by the included studies. Third, there is significant heterogeneity between studies. In order to examine the source of heterogeneity, we performed meta-regression with publication year, region, nationality, sample size in cases and controls, and definitions of cases and controls as independent variables. However, these variables could not explain the significant heterogeneity, suggesting that other unknown confounding factors may be the source of heterogeneity.
In summary, our study suggested that there was a significant association between −344T/C polymorphism in the CYP11B2 gene and hypertension in the Chinese population, especially in the Han Chinese. However, large-scale studies considering gene-gene and gene-environment interactions should be conducted to further investigate this association.
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